TU2670

· TiumBio Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TU2670, covering 2024-08-13 to 2024-08-13. Get the full timeline:

Most recent: Clinical Trial Update: TUC3PII-01_TU2670 Phase IIa Clinical Study [Phase 2]